Investing Ideas
/
Polish Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Polish Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Value score of at least 4 focused on companies with a low market cap.

2 companies

Genomed Spólka Akcyjna

Market Cap: zł33.6m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł25.40

5.8%

2.4%

Biogened

Market Cap: zł45.7m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.60

-41.9%